Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates nasal insulin (short-acting insulin aspart) for forgetfulness in Alzheimer's disease and mild cognitive impairment; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Nasal insulin (short-acting insulin aspart) (insulin aspart)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 1 | Status: COMPLETED